CRNX
Crinetics Pharmaceuticals Inc Earnings
$42.68
Earnings Summary
Revenue | $0.14Mn |
Net Profits | $-130.09Mn |
Net Profit Margins | -90972.73% |
Crinetics Pharmaceuticals Inc’s revenue jumped +Inf% since last year same period to $0.14Mn in the Q3 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -86.13% fall in its revenue since last 3-months.
Crinetics Pharmaceuticals Inc’s net profit fell -69.33% since last year same period to $-130.09Mn in the Q3 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -12.5% fall in its net profits since last 3-months.
Crinetics Pharmaceuticals Inc’s net profit margin jumped NaN% since last year same period to -90972.73% in the Q3 2025. On a quarterly growth basis, Crinetics Pharmaceuticals Inc has generated -711.1% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -1.23 |
EPS Estimate Current Year | -1.23 |
Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -1.23 - a -11.82% fall from last quarter’s estimates.
Crinetics Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -1.23.
Key Ratios
Earning Per Share (EPS) | 0 |
Crinetics Pharmaceuticals Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Crinetics Pharmaceuticals Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-08 | -0.95 | -1.04 | -9.21% |
2025-08-07 | -1.1 | -1.23 | -11.82% |
2025-11-06 | -1.23 | 0 | 100% |
